Covid-19 durante el embarazo y la lactancia

• Ministerio de Salud de la Nación 18-3-2020. Disponible en: https://www.argentina.gob.ar/salud/coronavirus-COVID-19/embarazadas
• https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-pregnancy-and-childbirth

1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.

1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506.
2. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395 (10223):507–513.
3. She J, Jiang J, Ye L, Hu L, Bai C, Song C. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Trans Med. 2020;9:19. doi:https://doi.org/10.1186/s40169-020-00271-z.
4. World Health Organization. Naming the coronavirus disease (COVID-2019) and the virus that causes it. https://www.who.int/emergencies/disease novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. Accessed February 23, 2020.
5. World Health Organization. Responding to community spread of COVID-19. Interim guiadance 2020, 1-6.
6. Siston AM, Rasmussen SA, Honein MA. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010; 303:1517–1525.
7. https://intergrowth21.tghn.org/ Acceso 5 de mayo, 2021
8. Villar J, Ariff S, Gunier R, et al. Maternal and Neonatal morbidity and mortality among pregnant women with and without Covid-19 infection. The INTERCOVID Multinational Cohort Study. JAMA Pediatr 2021; April 22
9. Papageorghiou A, Deruelle P, Gunier R, et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gyneco 2021;
10.  Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020; 370: m3320.
11.  Zhu F, Zozaya C, Zhou Q, et al. SARS-CoV-2 genome and antibodies in breastmilk: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed Epub ahead of print: [8th May 2021]. doi:10.1136/archdischild-2020-321074
12.  Perl S, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2–Specific Antibodies in Breast Milk After COVID-19 Vaccination of BreastfeedingWomen. JAMA. Published online April 12, 2021. doi:10.1001/jama.2021.5782
13.  Pace RM, Williams JE, Järvinen KM, et al. Characterization of SARS-CoV-2 RNA, antibodies, and neutralizing capacity in milk produced by women with COVID-19. mBio. 2021;12(1):1-11. doi:10.1128/mBio.03192-20
14. Academy of Breastfeeding Medicine. Considerations for COVID-19 vaccination in lactation. Accessed February 1, 2021. https://www. bfmed.org/abm-statement-considerations-for-covid-19-vaccination-in-lactation.
15. Diaz J. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J of Travel Med 2020; 27 (3): 41.
16. Organización Panamericana de la Salud y Consejo de Organizaciones Internacionales de las Ciencias Médica. Pauta 19: las mujeres durante el embarazo y la lactancia como participantes en una investigación (79-81). En: Pautas éticas internacionales para la investigación relacionada con la salud con seres humanos, Cuarta Edición. Ginebra: Consejo de Organizaciones Internacionales de las Ciencias Médicas (CIOMS); 2016.
17. Spong CY, Bianchi DW. Improving public health requires inclusion of underrepresented populations in research. JAMA. 2018;319(4):337-338. doi:10.1001/jama.2017.19138 18
18.  Adhikari E, Spong C. COVID-19 Vaccination in Pregnant and LactatingWomen. JAMA 2021; 16;325(11):1039-1040.
19.  https://www.argentina.gob.ar/sites/default/files/2021/04/evaluacion-inclusion-_nuevos-grupos-de-riesgo-en-vacunacion-contra-covid19-personas-gestantes-conain-_19-05-2021.pdf
20. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. Frater J, Ewer K, Ogber A et al.  The Lancet, June 18, 2021. DOI:https://doi.org/10.1016/S2352-3018(21)00103-X
21. Mendoza M, Garcia-Ruiz I, Maiz N, et al. Preeclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG 2020;127:1374–80.